BizCast host Shannon King talks with Arvinas CEO John Houston about the New Haven company's leadership in targeted protein degradation, a new way to treat diseases and cancers.

Houston also discusses why the quality of workforce talent and quality of life in Connecticut have boosted the growth of the bioscience and pharmaceutical industry in the state.

Please rate, review, and subscribe to the BizCast wherever you get your podcasts—we appreciate your support! If you have a story to tell, contact Shannon King.


Subscribe to CBIA BizCast on Apple or wherever you listen to your podcasts!